Globus Medical Inc (GMED): EBITDA
$756.66M
Year ended 2025-12-31
+36.7%
3-year compound annual growth
+34.1%
5-year compound annual growth
+14.4%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $756.66M | +80.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $419.38M | +50.5% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $278.67M | -5.9% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $296.20M | +22.5% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $241.82M | +38.7% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $174.31M | -22.4% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $224.72M | +6.5% | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | $210.96M | +3.5% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $203.91M | +5.7% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $192.91M | -1.7% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $196.31M | +22.6% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $160.12M | +32.3% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $121.07M | -8.9% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $132.90M | +16.3% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $114.31M | +11.1% | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $102.88M | n/a | 2013-06-13, From 2010-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Globus Medical Inc (GMED) | 2025-12-31 | $756.66M | +80.4% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $756.30M | +4.3% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | -$34.00M | n/m |
| Insulet Corp (PODD) | 2025-12-31 | $564.20M | +44.8% |
| ICU Medical Inc (ICUI) | 2025-12-31 | $243.57M | -7.2% |
| Teleflex Inc (TFX) | 2025-12-31 | $296.11M | +11.7% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.16B | +42.3% |
| ResMed Inc (RMD) | 2026-06-30 | $2.09B | +10.8% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $307.89M | +19.2% |
Compare GMED, WST, MMED, PODD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗